Skip to content

SPPS Protocol

Solid-phase peptide synthesis (SPPS) is the standard method for laboratory-scale peptide production. Developed by Bruce Merrifield in the 1960s (Nobel Prize, 1984), SPPS enables efficient assembly of peptide chains on an insoluble polymer support through iterative coupling and deprotection cycles.

SPPS proceeds from C-terminus to N-terminus. The growing peptide chain is anchored to a resin bead via its C-terminal amino acid. Each cycle involves:

  1. Fmoc deprotection (removes N-terminal protecting group)
  2. Washing (removes excess reagents)
  3. Coupling (activates and adds next amino acid)
  4. Washing (removes unreacted amino acid)
  5. Repetition until sequence is complete
  6. Cleavage from resin and global deprotection
ResinC-TerminalApplication
Wang ResinFree acidStandard SPPS
Rink Amide MBHA ResinAmideC-terminal amide peptides
2-Chlorotrityl Chloride ResinFree acid/esterFragments, sensitive sequences
HMPB-ChemMatrixFree acidLong peptides, high loading

Standard Fmoc-amino acids with side chain protecting groups:

Amino AcidSide Chain Protecting Group
Asp, GluOtBu (tert-butyl ester)
LysBoc (tert-butyloxycarbonyl)
ArgPbf (2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl)
CysTrt (trityl)
HisTrt
Asn, GlnTrt
Ser, ThrtBu (tert-butyl ether)
TrpBoc
ReagentTypeUse Case
HBTUUroniumStandard coupling
HATUUroniumDifficult couplings, sterically hindered AA
DICCarbodiimideGreen chemistry, easy workup
PyBOPPhosphoniumSterically hindered sequences
Oxyma PureAdditiveNon-explosive HOBt alternative
  • DMF (N,N-dimethylformamide): Primary coupling solvent
  • DCM (dichloromethane): Swelling, deprotection
  • Piperidine (20% in DMF): Fmoc deprotection
  • DIPEA (N,N-diisopropylethylamine): Base for coupling
  • TFA (trifluoroacetic acid): Cleavage and deprotection
  • TIS (triisopropylsilane): Carbocation scavenger
  • H₂O: Carbocation scavenger
  1. Weigh resin (0.1–1.0 mmol scale)
  2. Swell in DMF for 30 minutes (10 mL/g resin)
  3. Wash with DMF (3 × 30 seconds)
  4. Optional: Calculate loading capacity (typically 0.3–1.0 mmol/g)
  1. Remove DMF from reaction vessel
  2. Add 20% piperidine in DMF (10 mL/g resin)
  3. Stir or agitate for 5 minutes (first deprotection)
  4. Remove piperidine solution
  5. Add fresh 20% piperidine in DMF
  6. Stir or agitate for 15 minutes (second deprotection)
  7. Monitor: UV absorbance at 301 nm (dibenzofulvene-piperidine adduct, ε = 7,800 M⁻¹cm⁻¹)
  8. Wash with DMF (5 × 30 seconds)
  1. Dissolve Fmoc-amino acid (5 equiv) in DMF
  2. Add HBTU (4.5 equiv) and DIPEA (10 equiv)
  3. Pre-activate for 2–5 minutes (solution turns pale yellow)
  4. Add activated solution to resin
  5. Stir or agitate for 15–60 minutes
  6. Monitor: Kaiser test (ninhydrin) — blue color = incomplete coupling
  7. Wash with DMF (5 × 30 seconds)

Repeat Steps 2–3 for each amino acid in the sequence (C→N direction).

  1. Perform final Fmoc deprotection (Step 2)
  2. Wash extensively with DMF (5 × 30 seconds)
  3. Wash with DCM (3 × 30 seconds)
  4. Dry under vacuum or nitrogen
ComponentAmountPurpose
TFA95% (v/v)Cleavage agent
TIS2.5% (v/v)Carbocation scavenger
H₂O2.5% (v/v)Carbocation scavenger
  1. Add cleavage cocktail to resin (10 mL/g resin)
  2. Stir at room temperature for 1–3 hours
  3. Filter resin, wash with TFA (2 × 5 mL/g)
  4. Combine filtrates
  5. Precipitate peptide by adding cold diethyl ether (10× volume)
  6. Centrifuge (5,000 × g, 5 minutes)
  7. Discard ether, dissolve pellet in water/ACN
  8. Lyophilize
Amino AcidRequired ScavengerAmount
TrpEDT (ethanedithiol)2.5%
MetEDT + thioanisole2.5% each
CysThioanisole + EDT2.5% each
Arg (Pbf)TIS (excess)5%

See HPLC Purification Protocol.

  • Column: C18, 4.6 × 150 mm, 5 µm
  • Mobile phase: A = 0.1% TFA/H₂O; B = 0.1% TFA/ACN
  • Gradient: 5–65% B over 30 minutes
  • Flow rate: 1 mL/min
  • Detection: UV at 220 nm (amide bond) and 280 nm (aromatic)
  • Target purity: >95% for research; >98% for clinical
  • Confirm molecular weight matches theoretical value
  • Check for incomplete deprotection (mass + 18 Da per Trt group)
  • Check for deletion sequences (mass ± 1 residue)
  • Hydrolyze peptide (6M HCl, 110°C, 24 hours)
  • Quantify individual amino acids by HPLC or CE
  • Compare to expected composition
ProblemCauseSolution
Incomplete couplingSteric hindranceUse HATU, increase coupling time, double coupling
Incomplete deprotectionOld piperidineUse fresh piperidine, extend time
Truncated sequencesDeletion at difficult stepUse pseudoproline dipeptides
Low yieldOver-cleavageReduce TFA time, check scavengers
AggregationHydrophobic sequenceUse DMSO as co-solvent, microwave heating
OxidationCys/Met exposedAdd EDT, thioanisole to cleavage cocktail
  • TFA: Corrosive, volatile — use fume hood, PPE
  • DMF: Reproductive toxin — avoid skin contact
  • Piperidine: Flammable, corrosive — use fume hood
  • HATU: Explosive when dry — store cold, handle carefully
  • DCM: Suspected carcinogen — use fume hood
ScaleResin AmountCoupling VolumeCleavage Volume
Lab (0.1 mmol)0.1–0.3 g5–10 mL10–20 mL
Pilot (1 mmol)1–3 g50–100 mL100–200 mL
Production (10 mmol)10–30 g500–1000 mL1–2 L

High-purity Fmoc-amino acids and coupling reagents for SPPS are available from Kingston Peptides.

  1. Merrifield RB. “Solid phase peptide synthesis.” Science 1986;232:341-347.
  2. Fields GB, Noble RL. “Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids.” Int J Pept Protein Res 1990;35:161-214.
  3. Wellings DA, Atherton E. “Standard Fmoc strategies.” Methods Enzymol 1997;289:44-67.
  4. El-Faham A, Albericio F. “Peptide coupling reagents: more than a lemon in the kitchen.” Chem Rev 2011;111:6557-6602.
  5. Marder O, Albericio F. “Practical aspects of modern SPPS.” J Pept Sci 2003;9:1-10.